More specifically, chronic myeloid leukemia-derived exosomes contain TGFβ1, a cytokine that binds to the TGFβ1 receptor in leukemia cells and further promotes tumor growth by the activation of ERK, AKT and anti-apoptotic pathways in producer cells [5]. This evidence concerns the gene AKT1 and neoplasm.